Yokukansan Increases 5-HT1A Receptors in the Prefrontal Cortex and Enhances 5-HT1A Receptor Agonist-Induced Behavioral Responses in Socially Isolated Mice
暂无分享,去创建一个
A. Nishi | T. Ueki | Y. Kase | Y. Ikarashi | K. Mizoguchi | Takuji Yamaguchi | T. Hattori
[1] Y. Kase,et al. Specific binding and characteristics of geissoschizine methyl ether, an indole alkaloid of Uncaria Hook, in the rat brain. , 2014, Journal of ethnopharmacology.
[2] N. K. Popova,et al. Interplay between Serotonin 5‐HT1A and 5‐HT7 Receptors in Depressive Disorders , 2014, CNS neuroscience & therapeutics.
[3] K. Fuxe,et al. Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2. , 2013, Biochemical and biophysical research communications.
[4] N. Muma,et al. Estradiol potentiates 8-OH-DPAT-induced sumoylation of 5-HT1A receptor: Characterization and subcellular distribution of sumoylated 5-HT1A receptors , 2013, Psychoneuroendocrinology.
[5] H. Shoji,et al. Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats. , 2013, Journal of ethnopharmacology.
[6] N. Hirokawa,et al. A molecular motor, KIF13A, controls anxiety by transporting the serotonin type 1A receptor. , 2013, Cell reports.
[7] Taro Kishi,et al. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta‐analysis of randomized controlled trials , 2013, Human psychopharmacology.
[8] Yu Ohmura,et al. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. , 2012, Journal of ethnopharmacology.
[9] P. Heusler,et al. μ-Opioid and 5-HT1A receptors heterodimerize and show signalling crosstalk via G protein and MAP-kinase pathways. , 2012, Cellular signalling.
[10] Daria Guseva,et al. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking , 2012, Journal of Cell Science.
[11] A. Nishi,et al. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin1A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan , 2012, Neuroscience.
[12] A. Nishi,et al. The Blood–Brain Barrier Permeability of Geissoschizine Methyl Ether in Uncaria Hook, a Galenical Constituent of the Traditional Japanese Medicine Yokukansan , 2011, Cellular and Molecular Neurobiology.
[13] K. Takeuchi,et al. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[14] Takahiro A. Kato,et al. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease , 2009, Progress in Neuro-psychopharmacology and Biological Psychiatry.
[15] S. Barrondo,et al. Allosteric modulation of 5-HT1A receptors by zinc: Binding studies , 2009, Neuropharmacology.
[16] D. Richter,et al. Localization of the Mouse 5-Hydroxytryptamine1A Receptor in Lipid Microdomains Depends on Its Palmitoylation and Is Involved in Receptor-Mediated Signaling , 2007, Molecular Pharmacology.
[17] Z. Wasylewski,et al. Fluorescence studies of homooligomerization of adenosine A2A and serotonin 5-HT1A receptors reveal the specificity of receptor interactions in the plasma membrane. , 2007, Pharmacological reports : PR.
[18] R. Veh,et al. Mice over-expressing the 5-HT1A receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT , 2006, Behavioural Brain Research.
[19] Sung-Cheng Huang,et al. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Baba,et al. Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex , 2003, Neuropharmacology.
[21] D. Ciraulo. Neuropsychopharmacology: The Fifth Generation of Progress , 2003 .
[22] M. Esiri,et al. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease , 2003, Brain Research.
[23] Daniel Hoyer,et al. Molecular, pharmacological and functional diversity of 5-HT receptors , 2002, Pharmacology Biochemistry and Behavior.
[24] C. Queiroz,et al. Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[25] 陳進明,et al. Serotonin , 2001 .
[26] C. Sánchez,et al. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. , 1994, European journal of pharmacology.
[27] R. Rodgers,et al. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol , 1994, Psychopharmacology.
[28] D. Heal,et al. Characterization of 8‐OH‐DPAT‐induced hypothermia in mice as a 5‐HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants , 1992, British journal of pharmacology.
[29] H. J. Donkelaar,et al. Cell loss in the nucleus raphes dorsalis in alzheimer's disease , 1992, Neurobiology of Aging.
[30] H. V. Van Tol,et al. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. , 1990, The Journal of biological chemistry.
[31] C. de Montigny,et al. Electrophysiological Investigation of the Adaptive Response of the 5‐HT System to the Administration of 5‐HT1A Receptor Agonists , 1990, Journal of cardiovascular pharmacology.
[32] Y. Sugimoto,et al. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. , 1988, European journal of pharmacology.
[33] M. Hamon,et al. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[34] G. Goodwin,et al. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(DI-n-propylamino)tetralin (8-OH-DPAT) A model of presynaptic 5-HT1 function , 1985, Neuropharmacology.
[35] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.
[36] A. Hirano,et al. Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons , 1985, Annals of neurology.
[37] S. Hjorth,et al. 8-HYDROXY-2-(DIPROPYLAMINO)TETRALIN, A NEW CENTRALLY ACTING 5-HYDROXYTRYPTAMINE RECEPTOR AGONIST , 1982 .
[38] S. Hjorth,et al. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. , 1981, Journal of medicinal chemistry.
[39] T. Matsuda,et al. Potential role of serotonin1A receptors in post-weaning social isolation-induced abnormal behaviors in rodents. , 2014, Journal of pharmacological sciences.
[40] K. Sekiguchi,et al. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats. , 2009, The Journal of pharmacy and pharmacology.
[41] D. Blanchard,et al. An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT , 2005, Psychopharmacology.
[42] S. C,et al. Effects of the Traditional Chinese Herbal Medicine Yi-Gan San for Cholinesterase Inhibitor – Resistant Visual Hallucinations and Neuropsychiatric Symptoms in Patients With Dementia With Lewy Bodies , 2005 .
[43] J. Evenden,et al. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats , 2005, Psychopharmacology.
[44] W. Brooks,et al. Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation , 2004, Acta Neuropathologica.
[45] N. Cutler,et al. Generalised anxiety disorder: treatment options. , 2002, Drugs.
[46] H. Baumgarten,et al. Anatomy of central serotoninergic projection systems , 2000 .